1 active not recruiting, 1 enrolling by invitation, 1 unknown. 1 Not applicable, 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Enrolling by invitation 1 |
| Phase 3 | 1 | Enrolling by invitation 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Endothelin Receptor Antagonist: new trials by email Literature Review of Endothelin Receptor Antagonist trials Research Report on Endothelin Receptor Antagonist
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Endothelin Receptor Antagonism in Coronary Artery Spasm Endothelin Receptor Antagonist, Placebo control - Coronary Spasm | Phase 2 / Phase 3 | Enrolling by invitation | Radboud University Medical Center | 100 | 2024-11-11 | 2024-11-18 |
| Endothelin Role In COronary Microcirculation Cardiac MRI, Invasive Coronary Angiogram, Endothelin Receptor Antagonist - Coronary Microvascular Dysfunction (CMD), Angina Pectoris With Normal Coronary Arteriogram | Not applicable | Active not recruiting | Liverpool University Hospitals NHS Foundation Trust | 45 | 2023-07-01 | 2026-06-26 |
| the Effect of Tracleer on Tourniquet-associated Hypertension Tracleer 125Mg Tablet, Placebo - Tourniquets, Hypertension | Phase 4 | Unknown | Xuzhou Medical University | 80 | 2017-08-01 | 2017-07-25 |
Angina Pectoris (1) · Angina Pectoris, Variant (1) · Hypertension (1) · Microvascular Angina (1)
Liverpool University Hospitals NHS Foundation Trust (1) · Radboud University Medical Center (1) · Xuzhou Medical University (1)
China (1) · Netherlands (1) · United Kingdom (1)
Michael Fisher (1) · Peter Damman, MD, PhD (1) · Su Liu, doctor (1)